Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Human papillomavirus (HPV)
Rotavirus
2021
Americas
Clear all
Type of publications
NITAG documentation
(61)
Systematic reviews (SYSVAC)
(9)
Topics
Available to download in languages
Regions
Americas
(70)
Africa
(22)
Europe
(78)
South-East Asia
(3)
Western Pacific
(15)
Countries
Argentina
(1)
Bolivia
(2)
Canada
(16)
Chile
(9)
Mexico
(1)
United States of America
(40)
Diseases
COVID-19
(64)
Human papillomavirus (HPV)
(4)
Rotavirus
(2)
Ebola
(1)
Meningococcal disease
(1)
Vaccine topics
Acceptance
(4)
Administration
(1)
Coverage
(5)
Efficacy/effectiveness
(1)
Ethical issues
(4)
Safety
(1)
Target population
Adolescents
(4)
Adults
(5)
All age groups
(2)
Children
(5)
Healthcare workers
(1)
Newborn
(2)
Older adults
(1)
Parents/caregivers
(2)
Pregnant women
(4)
Publication date
2021
(70)
2024
(1)
2023
(12)
2022
(47)
2020
(65)
2019
(9)
2018
(10)
2017
(5)
2016
(16)
2015
(10)
2014
(10)
2013
(3)
2012
(1)
2011
(2)
2010
(4)
2009
(3)
2008
(4)
2007
(1)
70 results found
2021
∙
ACIP, Heather Scobie
Emerging SARS-CoV-2 Variants: Considerations for Vaccine - March 1st 2021
2021
∙
ACIP
Epidemiology of COVID-19 in Children and Teens
2021
∙
Sara Oliver, ACIP
EtR Framework: Janssen COVID-19 vaccine
2021
∙
NACI
Extended dose intervals for COVID-19 vaccines to optimize early vaccine rollout and population protection in Canada in the context of limited vaccine supply - 7 April, 2021
2021
∙
ACIP
Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): Janssen COVID-19 Vaccine
2021
∙
Julia Gargano, ACIP
Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): Janssen COVID-19 Vaccine
2021
∙
NACI
Guidance on booster COVID-19 vaccine doses in Canada – Update December 3, 2021
2021
∙
NACI, Public Health Agency of Canada
Guidance on the prioritization of key populations for COVID-19 immunization
2021
∙
Kathleen Dooling, ACIP
Implementation considerations for COVID-19 Vaccines
2021
∙
NACI
Interim guidance on booster COVID-19 vaccine doses in Canada
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register